All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec001}
============

Red blood cell (RBC) cryopreservation was described almost seventy years ago\[[@pone.0209201.ref001]\] and subsequently explored as means to prolong RBC storage prior to transfusion\[[@pone.0209201.ref002], [@pone.0209201.ref003]\]. Of note, RBC cryopreservation has never been optimized to satisfy research requirements, which differ from those for clinical use.

The main challenge in cryopreservation (i.e., the use of very low temperature to preserve intact cells\[[@pone.0209201.ref004]\]) is not endurance of extremely low temperature, but rather that of an intermediate temperature zone (approx. between -10 to -60°C) to which cells are exposed twice--during cooling and warming\[[@pone.0209201.ref005]\]. This intermediate temperature zone may damage cells due to imbalanced transmembrane water transport, a temperature-dependent process\[[@pone.0209201.ref006]\]. If water is not given enough time to exit, injury occurs from intracellular ice formation (IIF), leading to mechanical shearing\[[@pone.0209201.ref006], [@pone.0209201.ref007]\]. However, if water exits too quickly, injury may result from cell shrinkage and related changes in intracellular solute concentrations ("solution effects" injury)\[[@pone.0209201.ref008], [@pone.0209201.ref009]\]. Between these two ends of the spectrum, optimal cooling and warming rates exist that minimize freezing injury\[[@pone.0209201.ref010], [@pone.0209201.ref011]\].

Cryoprotective agents (CPAs) modulate membrane water transport\[[@pone.0209201.ref004]\] and inhibit intracellular ice formation. The most widely used CPA for RBC cryopreservation is glycerol, which enters cells via facilitated transport\[[@pone.0209201.ref012]\], whilst remaining nontoxic at high concentrations\[[@pone.0209201.ref013]\]. Two RBC glycerol cryopreservation protocols have been developed\[[@pone.0209201.ref014]\]: the high-glycerol (HGM; \~40%-50% w/v)\[[@pone.0209201.ref015], [@pone.0209201.ref016]\] and low-glycerol methods (LGM; \~15--20% w/v)\[[@pone.0209201.ref017], [@pone.0209201.ref018]\] ([Table 1](#pone.0209201.t001){ref-type="table"}). We focused on a HGM (40% v/v), due to material and equipment availability and simpler sample transport, on dry ice rather than in liquid nitrogen, which LGM requires.
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###### Comparison of the high-glycerol (HGM) and low-glycerol (LGM) methods for the cryopreservation of human RBCs.

![](pone.0209201.t001){#pone.0209201.t001g}

  CONDITIONS                            HGM (\~40--50% w/v)           LGM (\~15--20% w/v)
  ------------------------------------- ----------------------------- -----------------------
  Freezing Temperature                  ^-^80°C                       ^-^197°C
  Freezing Rate                         Slow (1C/min)                 Fast
  Freezing Technique                    Mechanical freezer            Liquid nitrogen
  Storage Temperature                   Min. ^-^65°C                  Min. ^-^120°C
  Impact of temperature changes         Thawing/refreezing possible   Highly destructive
  Transportation                        Dry ice                       Nitrogen vapor
  Time to deglycerolize                 Lengthy (60 min)              Moderate (30 min)
  Typical lysis following thaw          1--5% \[19--22\]              2--20% \[18, 23, 24\]
  Typical lysis following CPA removal   10--20% \[19--23, 25--27\]    5--13% \[18, 23\]

Adoption of glycerol-based RBC cryopreservation has been limited due to cost (money and time) of the deglycerolization process\[[@pone.0209201.ref028]--[@pone.0209201.ref030]\]. To prevent hypo-osmotic hemolysis during CPA removal, manual washing techniques have been developed using aqueous sugar\[[@pone.0209201.ref031]\] or salt\[[@pone.0209201.ref028]\]. Additionally, an automated system has been developed for clinical use\[[@pone.0209201.ref014]\], in which: (1) residual glycerol concentration is below threshold for hemolysis (of endogenous RBCs)\[[@pone.0209201.ref029]\], (2) final wash hemolysis is \<1%, and (3) 24h post-transfusion RBC recovery is \>75%, meeting current regulatory requirements\[[@pone.0209201.ref032]\]; however, total RBC loss is typically ~\~~15%\[[@pone.0209201.ref020]\]. This may be of clinical benefit, by culling damaged/senescent cells prior to transfusion. However, for research the goal is to obtain a RBC population identical to that circulating in subjects. Moreover, the most vulnerable cells are likely of greatest interest.

RBC assessment following cryopreservation has focused on basic *in vitro* analyses (hemolysis\[[@pone.0209201.ref002], [@pone.0209201.ref003], [@pone.0209201.ref021]\], morphologic\[[@pone.0209201.ref002], [@pone.0209201.ref033]\], rheologic\[[@pone.0209201.ref034]\], osmotic\[[@pone.0209201.ref002], [@pone.0209201.ref033], [@pone.0209201.ref034]\], surface marker\[[@pone.0209201.ref035]\], and biochemical\[[@pone.0209201.ref002], [@pone.0209201.ref003], [@pone.0209201.ref033]\]) and on *in vivo* survival\[[@pone.0209201.ref003], [@pone.0209201.ref021], [@pone.0209201.ref036]\], rather than on physiologic function (O~2~ transport, NO processing, vasoreactivity, and metabolism). Given new understanding of the pivotal role played by RBCs in vasoregulation\[[@pone.0209201.ref037]\], such analyses are relevant as well. Since such phenotypic analyses require intact cells, research has been limited by subject availability/proximity. To enable separation between subject and sample analysis, we identified need for research-optimized RBC cryopreservation, with simplified processing and maximized fidelity of recovered cells to *in vivo* phenotype. To achieve these goals, we developed a novel glycerolization procedure, minimizing front-end processing time. Additionally, we optimized a deglycerolization protocol, assessing sample osmolality and CPA removal at each step, thereby minimizing RBC lysis. Finally, to assess cryopreservation impact, we compared the phenotypic profile of cryopreserved/deglycerolized RBCs to that of fresh RBCs.

Methods {#sec002}
=======

Blood sampling and preparation of RBCs {#sec003}
--------------------------------------

This project was approved by the Washington University and Duke IRBs and written informed consent was obtained from all participants. Venous samples (EDTA or heparinized) were drawn from healthy volunteers. Unless otherwise stated, whole blood was centrifuged (1,500--2,000*g*, 10min, 4°C); plasma supernatant and buffy coat were removed prior to RBC preparation. All subsequent steps were carried out at RT, given that glycerol flux into RBCs is temperature dependent\[[@pone.0209201.ref038]\].

Standard glycerolization {#sec004}
------------------------

We followed a scaled-down step-wise cryopreservation procedure (40% w/v glycerol final), as reported\[[@pone.0209201.ref028], [@pone.0209201.ref038], [@pone.0209201.ref039]\] ([S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"}). Total processing time was \~25min ([Fig 1A](#pone.0209201.g001){ref-type="fig"}). Glycerolized samples were then placed into a Coolcell freezing container (Biocision, Larkspur, CA), ensuring rate-controlled freezing (-1°C/min when placed into a -80°C freezer).

![Optimization of an adapted glycerolization procedure and comparison to the standard reported literature method.\
**(A)** Diagram of the standard glycerolization protocol and our adapted method, designed to minimize sample processing time and allow collection/processing/storage of smaller RBC aliquots. In the standard glycerolization method, RBC volumes were added dropwise resulting in a final solution that was 40% w/v glycerol; in the adapted method, RBCs were added as a bolus, resulting in a final 40% v/v glycerol solution. All centrifugation was performed at 1,500*g*, 5min, at 4°C. **(B)** Whisker-plot comparing RBC lysis resulting from the addition of buffer/glycerol (60% v/v glycerol buffer stock added to samples) at different temperatures to pRBCs in a one step (bolus addition; 300μl pRBC to 600μl buffer/glycerol stock) or two step (300μl pRBCs to 300μl buffer to 300μl buffer/glycerol stock = step one, followed by addition of further 900μl buffer/glycerol stock = step two) process. Note, both procedures resulted in a 40% v/v glycerol final. Additionally in this experiment, no samples were frozen. Glycerol solutions were added and then samples immediately centrifuged and lysis measured. **(C)** Whisker-plot comparing the order of addition of pRBC, buffer, and buffer/glycerol (60% v/v glycerol buffer stock added to samples) in the two step glycerolization procedure, on the amount of lysis following sample freezing at -80°C and thawing for 2 minutes at 37°C. Order of addition of components is highly important. **(D)** Whisker-plot comparing RBC lysis following sample freezing and thawing, for the standard (40% w/v glycerol final) and our adapted (40% v/v glycerol final) glycerolization procedure. Mean RBC lysis was not different between the two methods; however, our adapted glycerolization procedure was 40% more time efficient (n = 9 matched samples from 3 individual blood donors).](pone.0209201.g001){#pone.0209201.g001}

Adapted glycerolization {#sec005}
-----------------------

We then modified the cryopreservation process to shorten processing and to allow collection of smaller sample volumes, more appropriate for research analysis ([Fig 1A](#pone.0209201.g001){ref-type="fig"}). Initial collection and centrifugation were unchanged from the standard protocol. Briefly, RBCs (300μl) were aliquoted from the bottom of the RBC pellet into cryopreservation tubes containing 300μl buffer and 300μl buffer/glycerol stock (60% v/v glycerol in starting buffer solution). Immediately thereafter, samples were mixed gently by repeated inversion, after which additional PBS-glycerol (900μl, 60% v/v glycerol in starting buffer solution) was added and the samples were again inverted (glycerol final 40% v/v; see [S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"}). Samples were then placed into a Coolcell freezing container. Matched fresh RBC samples were processed (washed 3X in PBS) for immediate analysis.

Deglycerolization {#sec006}
-----------------

Cryopreserved samples (40% v/v glycerol final) were thawed (37°C, 2min), inverted to mix, then transferred to Eppendorf tubes for centrifugation (1,500*g*, 5min, RT). The majority of supernatant (~\~~1.4ml) was removed, leaving ~\~~100μl layering the RBC pellet (~\~~300μl); this residual was inverted to gently resuspend RBCs (\~ 75% Hct) for subsequent deglycerolization.

Standard deglycerolization {#sec007}
--------------------------

We consolidated the published standard serial dilution procedure\[[@pone.0209201.ref028], [@pone.0209201.ref039]\]; deglycerolizing solutions were: 12% NaCI, 1.6% NaCI (unbuffered), followed by isotonic wash (0.8% NaCI, 0.2% glucose (11 mM), pH 7.4) ([Table 2](#pone.0209201.t002){ref-type="table"}). The process required \~50min ([Fig 2A](#pone.0209201.g002){ref-type="fig"}) (see [S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"}).

![Comparison of the standard and our adapted deglycerolization procedure.\
**(A)** Diagram of the standard deglycerolization protocol and our adapted method, designed to reduce RBC lysis. Samples (40% v/v glycerol final) were thawed (2min, 37°C), then centrifuged (1,500*g*, 5min, 4°C). For equilibration, samples were left undisturbed for 3min at RT. Circled numbers identify sampling points for the graphs presented in B-D. **(B)** Sample osmolality was measured at various stages of the standard and adapted deglycerolization methods. The adapted method slowed osmolality reduction during de-gycerolization, thereby protecting cells from lysis (n = 3--8 samples from 3 individual blood donors). **(C)** Total cumulative RBC lysis measured at different stages of the standard and adapted deglycerolization methods. RBC lysis was significantly reduced using the adapted deglycerolization method (n = samples, shown on graph. Minimum number of individual blood donors = 4). **(D)** Intracellular RBC glycerol measured at different stages of the standard and adapted deglycerolization methods. Both methods result in total glycerol removal (\> 99.9%) (n = 4--6 samples from 3 individual blood donors).](pone.0209201.g002){#pone.0209201.g002}
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###### Characteristics of the buffers used in sample glycerolization and deglycerolization.

![](pone.0209201.t002){#pone.0209201.t002g}

  Buffer                                     Molarity   NaCl (%)   Osmolality (mOsm)   pH
  ------------------------------------------ ---------- ---------- ------------------- --------
  PBS-glycerol (60% v/v glycerol in PBS)     10 mM      \-         8100                7.4
  PBS                                        10 mM      \-         280                 7.4
  Wash buffer 1 (12% NaCl)                   2.05 M     12         3700                Unbuff
  Wash buffer 2 (1.6% NaCl)                  274 mM     1.6        530                 Unbuff
  Wash buffer 3 (0.8% NaCl + 0.2% glucose)   137 mM     0.8        290                 7.4

Adapted deglycerolization {#sec008}
-------------------------

We optimized the above method to minimize RBC lysis by extending the dilution sequence (reducing osmolality less rapidly). The process required \~1hr ([Fig 2A](#pone.0209201.g002){ref-type="fig"}) (see [S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"}).

RBC lysis {#sec009}
---------

To determine the extent of RBC lysis, we assayed Hb concentration (\[Hb\]) spectrophotometrically (Biotek μQuant, Winooski, VT or FLUOstar Omega, BMG Labtech, Cary, NC) in both the post-centrifugation supernatant (numerator) and the original RBC-glycerol suspension (denominator), accounting volumes of each, and multiplying by 100 to index hemolysis to the starting total \[Hb\]. \[Hb\] assays and calculation of lysis percentage were repeated at each stage following cryopreservation, at various points during deglycerolization ([Fig 2A](#pone.0209201.g002){ref-type="fig"}) and successive washes. An alternative lysis calculation is outlined in [S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"}. \[Hb\] values from supernatants and RBC lysates did not differ whether measured by simple spectrophotometric or Drabkin's assays, using the following formula: $$Heme\ \left( {mM} \right) = \frac{\left( {sample\ absorbance\ @\ 540\ nM} \right)\ X\ \left( dilution\ factor \right)}{\left( {extinction\ coefficient\ @\ 540\ nM} \right)\ X\ \left( pathlength\ correction \right)}$$ where the extinction coefficient was 11mM^-1^cm^-1^ (this extinction coefficient is for the product of the reaction between Drabkins reagent and hemoglobin, i.e., cyanomethemoglobin) and the pathlength correction was 0.8 for a 300μl volume in a 96-well plate.

Sample osmolality {#sec010}
-----------------

Osmolality was determined by freezing point depression (Osmette A, Precision Systems Inc, Natick, MA).

Intracellular RBC glycerol concentration {#sec011}
----------------------------------------

Intracellular glycerol was determined using a Glycerol Assay kit (Sigma MAK117) and measured spectrophotometrically (A~570~; Biotek μQuant, Winooski, VT) (see [S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"}).

Scanning electron microscopy {#sec012}
----------------------------

See [S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"} for details; briefly, RBCs were fixed to poly-L-lysine coated coverslips, dehydrated in ethanol, dried (Leica EM CPD 300, Vienna, Austria), mounted on aluminum stubs and sputter coated with iridium (Leica ACE 600, Vienna, Austria), then loaded into a FE-SEM (Zeiss Merlin, Oberkochen, Germany) and imaged (3KeV, 300pA) using the Everhart Thornley secondary electron detector. Cell morphology was quantitated using a standard method\[[@pone.0209201.ref040]\]. Briefly, three separate images of cells (\~50--200 cells per image), either fresh, glycerolized, thawed, or deglycerolized, were counted and categorized according to shape, into one of six classes; (a) smooth disc (1.0), (b) crenated disc (0.8), (c) crenated discoid (0.6), (d) crenated spheroid (0.4), (e) crenated sphere (0.2), (f) smooth sphere (0). The percentage of each cell type was multiplied by the factor assigned to each cell type (in parentheses above), and the sum of these products was added together to calculate the morphological index (Im).

Standard RBC indices (CBC) {#sec013}
--------------------------

Standard RBC parameters including: mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and red cell distribution width (RDW) were measured using a conventional analyzer (Coulter ACT diff2, Beckman, Brea, CA).

Osmotic fragility {#sec014}
-----------------

Washed RBCs (50μL) were suspended in NaCl solutions (5ml) ranging from 0-10g/L and incubated (30min, RT). Intact RBCs were pelleted (2,000*g*, 10min, 4°C) and supernatant absorbance was read (540nm, Biotek μQuant, Winooski, VT). 100% lysis was assigned to the 0g/L NaCl solution, against which others were indexed.

RBC deformability {#sec015}
-----------------

RBCs in PBS (20*μ*l, 40% Hct) were added to iso-osmolar polyvinylpyrrolidone (5ml, viscosity \~30mPa\*s) (Mechatronics, Netherlands); RBC deformability (elongation index at 37°C and 0.3--30 Pa) was measured by ektacytometry (Laser-assisted Optical Rotational Red Cell Analyzer (LORRCA), RR Mechatronics, Hoorn, Netherlands).

RBC adhesion (*ex vivo*) {#sec016}
------------------------

RBC adhesivity to endothelium, in a custom variable height plexiglass flow chamber, was determined as described\[[@pone.0209201.ref041]--[@pone.0209201.ref044]\] (see [S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"}). Labeled RBCs (fluorescent dye PKH26) were introduced to the chamber (1.5ml/min), then allowed to dwell for 5--10min. The cell number at each location (height) was recorded. Then, 5--10min of fluidic flow was conducted with PBS at rates calculated to produce shear stress ranging 1--10dynes/cm^2^ and the number of adherent cells at each location was re-counted. Shear stress and percent adhesion were calculated at each height.

O~2~ affinity {#sec017}
-------------

O~2~-hemoglobin dissociation curves (ODC) were determined *in vitro* (Hemox-Analyzer, TSC Scientific, New Hope, PA). The p50 (pO~2~ at which HbSO~2~ is 50%) was extrapolated; the Hill co-efficient was also calculated from these data (TCS Hemox Data Aquisition System, TCS Scientific Corp, New Hope, PA).

RBC vasoactivity (hypoxic vasodilation, HVD) {#sec018}
--------------------------------------------

Male New Zealand white rabbits (n = 7; 1.8-2kg; strain code 052, Charles River) were euthanized (IV pentobarbital). The aorta was harvested and endothelium-intact rings were prepared for isometric tension recordings (Radnoti vascular ring array, Harvard Apparatus, Holliston, MA): 2gm resting tension, 37°C, Krebs, as described\[[@pone.0209201.ref045]\]. For each experiment, eight rings were run in parallel; n = 1 represents data averaged from rings with functional endothelium (\>60% ACh-induced relaxation following PE-induced pre-constriction)\[[@pone.0209201.ref045], [@pone.0209201.ref046]\]; percentage relaxation was calculated as the RBC-induced decrease in tension indexed to baseline plateau tension (during hypoxia; (95% N~2~ and 5% CO~2~)\[[@pone.0209201.ref046]\].

RBC NO content {#sec019}
--------------

Hb from fresh, frozen (without cryopreservation) and cryopreserved RBCs (deglycerolized or not) was assayed for total, Fe-bound and thiol-bound NO (SNO) content by photolysis/chemiluminescence, as described\[[@pone.0209201.ref047]\]. No sample treatment was used, other than desalting (G25) and paired analyses with/without HgCl~2~ (6-fold molar excess over \[Hb thiol\])\[[@pone.0209201.ref048], [@pone.0209201.ref049]\].

Metabolomics {#sec020}
------------

Metabolomics analyses and tracing experiments with \[1,2,3-^13^C~3~\]glucose were performed, as described\[[@pone.0209201.ref050], [@pone.0209201.ref051]\]. Either washed fresh, or glycerolized, frozen, thawed and deglycerolized RBCs (denoted deglycerolized; DG) were incubated with \[1,2,3-^13^C~3~\]glucose in the presence of (i) PBS (control), (ii) DMSO (vehicle control), or (iii) SOTS1 (superoxide donor) dosed to generate superoxide levels in the physiologically relevant range produced by activated NADPH oxidase\[[@pone.0209201.ref052], [@pone.0209201.ref053]\]. Sampling was performed at 0, 1, 3 and 6hrs from separated cells and supernatants (2,000*g*, 10min, 4°C). Catabolism of \[1,2,3-^13^C~3~\]glucose generates distinct lactate isotopologues, namely ^13^C~2~ (M+2) and ^13^C~3~ (M+3), depending on whether glucose oxidation preferentially occurs through the pentose phosphate pathway (PPP) or the Embden-Meyerhof-Parnas (EMP) glycolytic pathway, respectively.

Samples were prepared for UHPLC-MS metabolomics, as described\[[@pone.0209201.ref050]\] (also, see [S1 Extended Methods](#pone.0209201.s001){ref-type="supplementary-material"}). The Q Exactive mass spectrometer (Thermo, Bremen, Germany) was operated in Full MS mode (2μscans) at 70,000 resolution in the 60-900m/z range, 4kV spray voltage, 15 sheath gas and 5 auxiliary gas, in positive and negative ion modes (separate runs). Metabolite assignments and isotopologue distributions were determined using the software Maven (Princeton, NJ)\[[@pone.0209201.ref054]\] and assignments confirmed against 700 standards (IROATech, Sigma Aldrich, St. Louis, MO).

Partial-Least Square Discriminant Analysis (PLS-DA), hierarchical clustering analysis (Pearson correlation, complete linkage) and heat maps were plotted with MetaboAnalyst 4.0\[[@pone.0209201.ref055]\] and GENE E (Broad Institute, Cambridge, MA).

In vivo analysis of RBC adhesion, RBC velocity, and Hb saturation {#sec021}
-----------------------------------------------------------------

Nude mice (n = 16; *Foxn1*^*nu*^; Jackson Labs, strain 002019) were anesthetized (isoflurane) and fitted with a dorsal window chamber, as described\[[@pone.0209201.ref056]\]. After recovery (1-3d), mice were anesthetized (isoflurane), placed upon a temperature-controlled platform and inspected to verify intact microcirculation. PKH-26 labeled RBCs (10μL/g body weight) were infused over 10sec and label movement was tracked by intravital microscopy (5X, Zeiss Axioobserver Z1, Zeiss Zen software). Videos (transmission and red fluorescent channel) and still images of the microvasculature were captured for each subject and analyzed offline for RBC adhesion, RBC velocity, and Hb saturation (ImageJ, NIH)(MatLab R2017b, Mathworks)\[[@pone.0209201.ref057]\].

Adhesion was measured by time-averaging a \~60sec sequence, yielding a composite image in which adherent cells appeared as distinct fluorescent entities, while moving cells blurr. Individual adherent RBCs were then hand-counted. Adhesion values for each subject were calculated and presented as percent adherent cells relative to total cells present in a single frame.

To measure RBC velocity, five venules of various sizes were randomly selected from each subject's video. Individual RBCs were selected from these venules, then tracked through 5--10 frames of movement. Because individual RBC velocities through different venules is non-uniform, two cells were selected from a particular venule and their velocities through a shared segment of that venule were averaged. Venule diameter was measured perpendicular to the mid-point of the travel path. Each two-cell velocity average was then normalized to the inverse square of the radius of the venule segment through which the cells passed. This provided five normalized RBC velocities per subject, which were then averaged to yield a single (n = 1) average radius^2^-normalized RBC velocity per subject.

To measure Hb saturation, still images of each subject were taken at a range of wavelengths and processed (Matlab) to generate a Hb saturation heat map of the region's venules\[[@pone.0209201.ref056]\]. Five segments corresponding to those used for the velocity analysis were selected for each subject. The Hb saturation values of these segments were averaged to give a single final averaged Hb saturation percentage value for each subject.

Statistical analyses {#sec022}
--------------------

Results are presented as mean ± standard error of the mean (SEM). Column statistics were performed to determine data distribution normality. Where appropriate, groups were compared by t-test (Student's or Wilcoxon rank) or repeated measures analysis of variance (RMANOVA; Bonferroni's posthoc test) (PRISM, GraphPad Inc.; La Jolla, CA).

Results {#sec023}
=======

RBC glycerolization {#sec024}
-------------------

We initially attempted glycerolizing RBCs in one-step, adding 60% v/v buffer/glycerol solution to pelleted RBCs (40% v/v, glycerol final). The effect of temperature on this process was significant, with warmer glycerol resulting in less RBC lysis ([Fig 1B](#pone.0209201.g001){ref-type="fig"}). This method resulted in lysis (prior to freezing) of \~10%, which we considered unacceptable. We then optimized a two-step method (similar to that reported\[[@pone.0209201.ref028], [@pone.0209201.ref038], [@pone.0209201.ref039]\]). We found the order of component addition to strongly influence hemolysis; adding buffer (PBS 300μl) and 300μl buffer/glycerol stock (60% v/v glycerol in starting buffer solution) to the tube first, followed by RBCs (300μl), resulted in lowest lysis ([Fig 1C](#pone.0209201.g001){ref-type="fig"}). We also tested thawing temperature (37°C *vs* 50°C) as well as different cryopreservative tubes (Biocision TruCool cryogenic vials \#BCS-2502 and 2504, Larkspur, CA; Corning cryogenic vials \# 430487, NY; ThermoFisher Scientific Abgene storage tubes \# AB1411, Waltham, MA) and tube sizes (TruCool, Biocision, Larkspur, CA \# BCS-2502, \#BCS-2504), but no significant differences were observed (not shown). In comparison to standard glycerol cryopreservation\[[@pone.0209201.ref038], [@pone.0209201.ref039]\], our adapted procedure ([Fig 1A](#pone.0209201.g001){ref-type="fig"}) resulted in similar % lysis (1.18% ± 0.2% vs 0.88% ± 0.1%, standard vs adapted, respectively; [Fig 1D](#pone.0209201.g001){ref-type="fig"}), following sample freeze/thaw (-80°C overnight in a Coolcell and next-day thawing (37°C, 2min)); of note, sample processing time was reduced by 40% (from 25 to 15min).

RBC deglycerolization {#sec025}
---------------------

With the standard deglycerolization method\[[@pone.0209201.ref028], [@pone.0209201.ref039]\] ([Fig 2A](#pone.0209201.g002){ref-type="fig"}), we observed total cumulative lysis of 13.0% ± 1.5%, from thawing to complete glycerol removal ([Fig 2C](#pone.0209201.g002){ref-type="fig"}). Consequently, to reduce lysis, we slowed the rate at which osmolality was lowered during deglycerolization ([Fig 2B](#pone.0209201.g002){ref-type="fig"}). With this adapted method, total cumulative lysis fell to 8.4% ± 0.3% (p\<0.05, \~ 35% reduction) ([Fig 2C](#pone.0209201.g002){ref-type="fig"}). Glycerol concentration was measured to ensure full CPA removal (\>99.9% for both the standard and adapted deglycerolization protocols, [Fig 2D](#pone.0209201.g002){ref-type="fig"}).

Standard morphological imaging (SEM) and measurement (CBC) {#sec026}
----------------------------------------------------------

SEM images were acquired at each stage of sample assessment ([Fig 3A](#pone.0209201.g003){ref-type="fig"} and [S1 Fig](#pone.0209201.s002){ref-type="supplementary-material"}). Fresh RBCs demonstrated the characteristic bi-concave disc shape, with minimal morphological variance. Following glycerolization, the majority of cells appeared spherocytic, as reflected in the low morphological index (Im = 40.6 ± 2.1). After thawing, RBCs were observed to be embedded in a highly structured cryopreservation matrix, with almost all cells demonstrating a crenated sphere morphology (Im = 20.1 ± 0.1). Following full deglycerolization, cell morphology was indistinguishable from that for fresh RBCs, with no significant difference in morphological index (Im = 97.1 ± 1.1 vs 99.1 ± 0.2, respectively; paired t-test p = 0.26).

![RBC morphological imaging (scanning electron microscope; SEM) and comparison of osmotic fragility, deformability, and *ex vivo* adhesion in matched fresh and deglycerolized RBCs.\
**(A)** Illustration of the characteristic biconcave disc morphology of fresh RBCs. Following glycerol addition, the majority of RBCs become swollen and spherocytic. After thawing, RBCs remain encapsulated in a glycerol matrix. Following deglycerolization RBCs return to their original morphology. **(B)** NaCl induced osmotic lysis in matched fresh, deglycerolized, and deglycerolized RBCs exposed to a prolonged buffer incubation (n = 5 or 10 individual donors, shown on graph). NaCl induced osmotic lysis increased immediately following deglycerolization, but returned to the original fresh phenotype following prolonged incubation (1 hour) of RBCs in the final deglycerolization buffer. **(C)** Half maximal effective concentration (EC~50~) increased immediately following deglycerolization, in comparison to fresh RBC samples (p \< 0.05). However, prolonged incubation (1 hour) of RBCs in the final deglycerolization buffer at 37°C restored the original fresh RBC phenotype (n = 5 or 10 individual donors, shown on graph). **(D)** Shear induced maximal RBC deformability (Elongation Index maximum; EI~max~) was not different between matched fresh and deglycerolized RBCs (exposed to the prolonged buffer immersion) (n = ±6 individual donors). **(E)** The shear stress (Pa) at which RBC demonstrated 50% elongation (SS~50~) was also not different between matched fresh and deglycerolized RBCs (exposed to the prolonged buffer immersion) (n = 6 individual donors). **(F)** RBC adhesivity to endothelium was determined *ex vivo*. A trend was observed toward a decrease in RBC adhesivity in the deglycerolized RBCs, across all sheer stresses \> 1 dyne/cm^2^, that did not reach statistical significance.](pone.0209201.g003){#pone.0209201.g003}

RBC morphometric indices complemented the qualitative SEM images. Compared to fresh RBCs, glycerolization increased MCV (91.2 ± 2.1fL vs 109.7 ± 1.7fL; p\<0.05; [S1 Fig](#pone.0209201.s002){ref-type="supplementary-material"}), without altering MCH ([S1 Fig](#pone.0209201.s002){ref-type="supplementary-material"} this was corroborated by MCHC decrease (32.2 ± 0.3g/dL vs 26.7 ± 0.3g/dL; p\<0.05; [S1 Fig](#pone.0209201.s002){ref-type="supplementary-material"}), corresponding to observed spherocytic morphology (SEM). Glycerolization also increased RDW, compared to fresh RBCs (34.5 ±0.8% vs 13 ± 0.3%, respectively; p\<0.05; [S1 Fig](#pone.0209201.s002){ref-type="supplementary-material"}). Following full deglycerolization, all parameters returned to levels observed for fresh RBCs.

*In vitro* physiologic measurements {#sec027}
-----------------------------------

### Cell volume regulation (osmotic fragility) {#sec028}

When measured immediately following deglycerolization, storage in glycerol and full deglycerolization increased RBC osmotic fragility (i.e., cells lysed at a higher tonicity \[in NaCl solution\] in comparison to fresh RBCs); the half-maximal effective NaCl concentration \[EC~50~\] increased (from 4.39 ± 0.09g/L to 4.66 ± 0.07g/L, p\<0.05; [Fig 3B and 3C](#pone.0209201.g003){ref-type="fig"}). However, resting RBCs in the last deglycerolization buffer (1h, 37°C) restored osmotic resilience to levels observed in fresh RBCs (4.39 ± 0.09g/L to 4.37 ± 0.09g/L; [Fig 3B and 3C](#pone.0209201.g003){ref-type="fig"}).

### Deformability {#sec029}

Deformability of deglycerolized and fresh RBCs was identical across a physiologically relevant range of shear stress ([Fig 3D](#pone.0209201.g003){ref-type="fig"}). The shear stress at which RBCs demonstrated 50% elongation (SS~50~) was did not differ between fresh and deglycerolized RBCs (following prolonged buffer immersion) ([Fig 3E](#pone.0209201.g003){ref-type="fig"}).

### Adhesion {#sec030}

A trend was observed toward decreased *ex vivo* RBC adhesivity in deglycerolized compared to fresh RBCs, across all sheer stresses \>1dyne/cm^2^; this did not reach statistical significance ([Fig 3F](#pone.0209201.g003){ref-type="fig"}).

### O~2~ affinity {#sec031}

No difference was observed in the O~2~-hemoglobin dissociation curves from matched fresh and deglycerolized RBC samples (BIS TRIS 50mM, NaCl, 100mM) ([Fig 4A](#pone.0209201.g004){ref-type="fig"}), nor in p50, cooperativity ([Fig 4B](#pone.0209201.g004){ref-type="fig"}) and Bohr effect ([Fig 4C](#pone.0209201.g004){ref-type="fig"}).

![Comparison of O~2~ dissociation curves (ODCs) and RBC hypoxic vasodilatory response (HVD) from matched fresh and deglycerolized RBCs, and NO content of matched fresh RBCs, frozen RBCs (without glycerol), cryopreserved RBCs (without glycerol removal), and cryopreserved RBCs (deglycerolized), measured by photolysis:chemiluminescence.\
**(A)** Raw ODC curves from matched fresh and deglycerolized RBCs in BIS TRIS buffer (BIS TRIS 50mM, NaCl, 100mM), pH to 7.2, 7.4, and 7.6. Inset is the whole ODC curve (n = 10 individual donors). No difference was observed between fresh and deglycerolized RBCs. **(B)** Hill coefficient, a measure of cooperativity, was not different between matched fresh and deglycerolized RBC samples across the 3 different pH values. **(C)** Bohr plot demonstrates no change between matched fresh and deglycerolized RBC samples. **(D)** Representative single traces (from rings demonstrating similar PE constriction responses) of the relaxation responses from fresh *vs* deglycerolized RBCs under hypoxia (\~ 1% O~2~)---Arrow indicates injection point for RBCs. **(E)** Relaxation responses of fresh and deglycerolized RBCs (as a percentage of maximal constriction) are not different in a hypoxic organ chamber bioassay of endothelial intact rabbit aortic rings. **(F)** Total RBC NO content was not significantly different between any of the conditions, although freezing appeared to slightly augment NO levels. **(G)** Iron nitrosyl hemoglobin (HbFeNO) content remained unchanged in all conditions. **(H)** S-nitrosohemoglobin (SNO-Hb) significantly increased upon freezing, independent of glycerol presence (p \< 0.05). Data reported as NO:Hb (tetramer basis).](pone.0209201.g004){#pone.0209201.g004}

### RBC-based hypoxic vasodilatory response {#sec032}

In an organ-chamber bioassay of endothelium-intact rabbit aortic rings held at low O~2~ tension (\~1% O~2~), matched fresh and deglycerolized RBCs demonstrated similar vasodilation ([Fig 4E](#pone.0209201.g004){ref-type="fig"}). Single representative traces were plotted to visually demonstrate the relaxation response ([Fig 4D](#pone.0209201.g004){ref-type="fig"}).

### RBC NO content {#sec033}

Photolysis-chemiluminescence was used to measure RBC hemoglobin NO content in matched: fresh, frozen (without glycerol) and cryopreserved RBCs (without/with glycerol removal). Total Hb NO content was not significantly different between any of the conditions, although freezing (regardless of glycerol addition) appeared to slightly augment NO levels ([Fig 4F](#pone.0209201.g004){ref-type="fig"}). Iron nitrosyl hemoglobin (HbFeNO) content remained unchanged in all conditions ([Fig 4G](#pone.0209201.g004){ref-type="fig"}). However, S-nitrosohemoglobin (SNO-Hb) levels increased upon sample freezing ([Fig 4H](#pone.0209201.g004){ref-type="fig"}), independent of glycerol presence or removal (fresh: 0.0038 ± 0.001; frozen: 0.0095 ± 0.002; cryopreserved w/o deglycerolization: 0.011 ± 0.001; cryopreserved, deglycerolized: 0.010 ± 0.002; expressed as NO:Hb molar ratio; tetramer basis, for all; p\<0.05).

Biochemical analysis {#sec034}
--------------------

### Metabolomics--steady state phenotypes and metabolic fluxes in response to oxidant stress {#sec035}

UHPLC-MS metabolomics were performed to compare phenotypes of fresh vs cryopreserved and deglycerolized RBCs ([Fig 5A--5H](#pone.0209201.g005){ref-type="fig"}). Analyses of both RBCs and media indicated similar glucose consumption rates ([Fig 5D and 5F](#pone.0209201.g005){ref-type="fig"}) and total lactate generation ([Fig 5E and 5G](#pone.0209201.g005){ref-type="fig"}) in both groups over a 6h time course. Oxidative loading (SOTS-1) was employed to unveil more subtle metabolic differences between fresh and deglycerolized RBCs, by extending the dynamic range for metabolite flux. Supplementation to the media of \[1,2,3-^13^C~3~\]glucose was used to determine the rate of lactate isotopologue enrichment via glycolysis (M+3) or the pentose phosphate pathway (M+2). Results indicated that fresh RBCs were characterized by significantly higher levels of supernatant--but not intracellular---M+2 lactate ([Fig 5H](#pone.0209201.g005){ref-type="fig"}). Conversely, deglycerolized RBCs were characterized by faster glycolysis than fresh RBCs ([Fig 5H](#pone.0209201.g005){ref-type="fig"}). Even though lower lactate M+2 export in deglycerolized RBCs following SOTS-1 was observed, intracellular glycolysis to pentose phosphate pathway ratios were comparable between fresh and deglycerolized RBCs following treatment with SOTS-1 ([Fig 5H](#pone.0209201.g005){ref-type="fig"}). Deglycerolized RBCs were also characterized by lower levels of oxidized glutathione (GSSG) and higher reduced to oxidized glutathione ratios (GSH/GSSG) in comparison to fresh RBCs treated with SOTS-1, suggestive of decreased oxidative damage upon oxidative loading, in comparison to SOTS-1-treated fresh RBCs (not shown).

![Comparison of metabolomic steady state phenotypes and metabolic fluxes in response to oxidant stress in fresh and matched deglycerolized RBCs.\
**(A)** Tracing experiments were performed by incubating RBCs with \[1,2,3-^13^C~3~\]glucose, a heavy substrate that can be metabolized in RBCs through **(B)** the Embden-Meyerhof-Parnas (EMP) glycolytic pathway (generating isotopologue M+3) or through the pentose phosphate pathway (PPP), generating isotopologue M+2 of lactate, **(C)** owing to the release of the first carbon atom of heavy glucose in the form of ^13^CO~2~ at the oxidative phase reactions of the PPP. **(F)** Schematic overview of glucose uptake and consumption in RBC supernatants and cells, in fresh, or deglycerolized RBCs, either untreated, or treated with the superoxide generator (SOTS-1), **(D)** demonstrating in both RBCs and media similar glucose consumption rates. **(E)** Total lactate, i.e., sum of lactate isotopologues (unlabeled M+0, M+3 generated via glycolysis, or M+2 generated via the PPP), in fresh and DG RBCs, either untreated or treated with the superoxide generator (SOTS-1), demonstrating in both RBCs and media similar lactate accumulation. **(G and H)** Schematic overview of expected isotopologues and relative ratios of lactate, from glycolysis (EMP, M+3 isotopologue) or PPP (M+2) and relative ratios in fresh and DG RBCs, either untreated, or treated with the supoxide generator SOTS-1. **(H)** Fresh RBCs were characterized by significantly higher levels of supernatant--but not intracellular---M+2 lactate. Conversely, deglycerolized RBCs were characterized by faster glycolysis than fresh RBCs. Lower lactate M+2 export in deglycerolized RBCs following SOTS-1 was observed, while intracellular glycolysis to pentose phosphate pathway ratios were comparable between fresh and deglycerolized RBCs following treatment with SOTS-1. Continuous lines indicate median, while dashed lighter lines are representative of interquartile ranges, according to the color legend left. Symbols indicate p\<0.05 **+** = fresh vs DG; **&** = fresh + SOTS vs DG + SOTS; **\*** = fresh vs fresh + SOTS; **\#** = DG vs DG + SOTS.](pone.0209201.g005){#pone.0209201.g005}

Considering the minor differences noted in (above) tracing exeperiments, to further compare the metabolic phenotypes of fresh and cryopreserved RBCs, we performed unsupervised analyses of metabolomics data via PLS-DA ([Fig 6A](#pone.0209201.g006){ref-type="fig"}) and hierarchical clustering. Dendrograms for time course data from control vs DG +/- SOTS-1 are shown in [Fig 6B](#pone.0209201.g006){ref-type="fig"}. The impact of time and oxidative loading (SOTS-1) informed sample clustering along principal components 1 and 2 (explaining 21.9 and 17.4% of the total variance, respectively). Both PLS-DA and hierarchical clustering analyses confirmed that control and DG groups fell into identical clusters at the tested time points, both in the absence and presence of SOTS ([Fig 6A and 6B](#pone.0209201.g006){ref-type="fig"}). Results are further shown in the form of heat maps ([Fig 6C](#pone.0209201.g006){ref-type="fig"} and [S2 Fig](#pone.0209201.s003){ref-type="supplementary-material"}), visually indicating a time course and SOTS-1 dependency of the metabolic phenotypes observed both in control and DG groups. The only notable exception was glycerol-phosphate, a product of glycerol metabolism, observed to be significantly higher in DG RBCs at 0h time point and declining to 0h control levels just after 6h.

![Unsupervised analysis of metabolomics data via PLS-DA, with dendrograms for time course hierarchical clustering and heat maps, visually indicating a time course and SOTS dependency of the metabolic phenotypes observed in fresh RBC and matched DG RBCs.\
**(A)** The impact of time and SOTS treatment informed sample clustering along principal components 1 and 2 (explaining 21.9 and 17.4% of the total variance, respectively). Both **(A)** PLS-DA and **(B)** hierarchical clustering analyses confirmed that control and DG groups fell into the same clusters at the tested time points, both in the absence and presence of SOTS. **(C)** Heat maps visually indicate the time course and SOTS dependency of the metabolic phenotypes observed both in fresh RBC and DG groups.](pone.0209201.g006){#pone.0209201.g006}

In vivo RBC analysis {#sec036}
--------------------

### RBC response to transfusion in nude mice (mapped hemoglobin O~2~ saturation, RBC velocity, and RBC adhesion) {#sec037}

Post-transfusion function of human RBCs was assessed in a nude mouse model ([Fig 7A](#pone.0209201.g007){ref-type="fig"}), with comparison made between fresh or deglycerolized RBCs. Labeled human RBCs were transfused into healthy nude mice in volumes mimicking a 2-unit transfusion in an adult human. As described\[[@pone.0209201.ref058], [@pone.0209201.ref059]\], control fresh healthy human RBCs did not alter blood hemoglobin O~2~ saturation maps. There was also no effect on (transfused) RBC velocity. Adhesion of control transfused human RBCs *in vivo* was low, and adhesion of transfused DG RBCs did not differ significantly.

![Dorsal window chamber set up for the assessment of *in vivo* hemoglobin O~2~ saturation, RBC velocity and vascular adherence of transfused fresh or matched deglycerolized RBCs.\
**(A)** Image of the dorsal window chamber set up. **(B** and **C)** No difference was observed in mapped hemoglobin O~2~ saturation, or **(D)** RBC velocity in the dorsal skinfold window chamber model, between the transfusion of fresh or deglycerolized RBCs. **(E)** A modest, but statistically insignificant difference was observed on *in vivo* adhesivity of transfused RBCs between fresh and deglycerolized RBCs from the same donors.](pone.0209201.g007){#pone.0209201.g007}

We found that the cryopreservation protocol did not alter mapped hemoglobin O~2~ saturation in a dorsal skinfold window chamber model either qualitatively or in quantitative Hb saturation analysis ([Fig 7B and 7C](#pone.0209201.g007){ref-type="fig"}), nor was RBC velocity altered ([Fig 7D](#pone.0209201.g007){ref-type="fig"}). There was a modest but statistically insignificant effect of cryopreservation on *in vivo* adhesivity of transfused RBCs ([Fig 7E](#pone.0209201.g007){ref-type="fig"}), as compared to that of fresh human RBCs from the same donors.

Discussion {#sec038}
==========

Here, we report a RBC cryopreservation protocol optimized to satisfy requirements particular to RBC research. This protocol improved glycerolization efficiency (\~40% time reduction to achieve 40% v/v, glycerol final) and was equivalent to the standard method\[[@pone.0209201.ref028], [@pone.0209201.ref038], [@pone.0209201.ref039]\] in terms of RBC recovery following freezing (-80°C) and thawing (37°C). Of note, following full glycerol removal (\>99.9%), our modified procedure reduced total cumulative lysis by \~35%, in comparison to the standard method. These improvements minimize the burden of initial sample processing, render cryopreservation protocols more feasible for clinical research staff, improve RBC recovery following cryopreservation and enable analyses of vulnerable RBC sub-populations that might otherwise be lost. Our modified methodology resulted in a post-cryopreservation/deglycerolization RBC phenotype that was indistinguishable from that of fresh RBCs, with regard to physical RBC parameters (morphology, volume, and density), osmotic fragility, deformability, endothelial adhesivity, O~2~ affinity, vasoregulation, metabolomics, and flow dynamics.

In the process of inter-laboratory method validation, we noted that sample handling during both the glycerolization and deglycerolization procedures influenced RBC lysis amount. Others\[[@pone.0209201.ref034]\] have also reported that RBC sample processing contributes more to cryostored RBC quality than does storage duration. Specificially, we determined that when adding packed RBCs to glycerolizing solutions, immediate gentle sample inversion (to fully suspend cells) was necessary to prevent RBC clumping and greater post-thaw lysis. Similarly, throughout the deglycerolization procedure, lysis was increased by excessive agitation or tube plucking/tapping to accelerate RBC re-suspension. Ultimately, simple rotation of the tube on its axis (to mix the sample) proved optimal. We did not address the effect of storage duration on RBC recovery or phenotype fidelity, as all samples were analyzed and measured within a month of freezing.

Our cryopreservation protocol was specifically developed for maximal recovery of human RBCs. It should be noted that plasma osmolality\[[@pone.0209201.ref060]--[@pone.0209201.ref062]\] as well as RBC size and volume (and subsequently surface area to volume ratios)\[[@pone.0209201.ref063]--[@pone.0209201.ref068]\] differ widely across species commonly used in RBC research, all of which may contribute to differing tolerance to osmotic and mechanical stress. It is thus likely that species-specific adjustments to this cryopreservation protocol may be needed to attain similar results. Additionally, even with human RBCs, we still observed 8% lysis following cryopreservation. We speculate that the cells lost may represent cells or cell sub-population(s) least resilient to osmotic or mechanical stress, suggesting possible need for additional method validation prior to study of subjects with such pathologies. With this in mind, while we focused on glycerol as our CPA due to its lack of toxicity and extensive literature on its clinical use, other cryoprotectants are available (both cell-penetrating and non-cell penetrating) that might better address this issue.

The finding that there was a small degree of baseline adhesion of control transfused human RBCs is in agreement with prior published findings\[[@pone.0209201.ref058], [@pone.0209201.ref059]\]. It is possible that the slightly larger size of human red cells may lead to pseudostatic appearance in mouse capillaries, where some fraction of the transfused RBCs might require a slightly longer transit time. In addition, there may be infrequent, random adhesion of even murine RBCs to murine (or human to human) endothelium *in vivo*. The adapted cryopreservation technique did not increase RBC adhesivity.

Unsupervised analyses of metabolomics data confirmed similarity of metabolic phenotypes of fresh and deglycerolized RBCs, both at rest and under oxidant loading conditions, affirming the conclusion that our research-optimized procedure for RBC cryopreservation and deglycerolization in 40% v/v glycerol final does not significantly impact RBC phenotype (compared to fresh cells).
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